QDEL, US2197981051

QuidelOrtho stock spotlights AI in laboratory operations

Published on 10/30/2026 at 00:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

QuidelOrtho stock was quoted at 12.31 euros by Lang & Schwarz late on October 29. The company released a new Science Bytes episode on laboratory AI.

AI and Informatics Take Center Stage

QuidelOrtho's latest Science Bytes episode examines how AI and informatics can improve laboratory workflows.
The company emphasized standardized, reliable and traceable data as a prerequisite for useful AI applications.
The discussion also covers workforce shortages and applications in transfusion medicine.

QDEL, US2197981051, Illustration mit AI erstellt.

QuidelOrtho is using its latest Science Bytes episode to focus attention on artificial intelligence and informatics in clinical laboratories. The company announced the release on October 29, according to WFMZ, carrying the company release.

From Fragmented Data to Decisions

Episode 62 of QuidelOrtho's Science Bytes podcast explores how structured data systems can turn results from separate laboratory platforms into usable clinical knowledge. Rodney Guzman, the company's vice president of software engineering for global informatics platforms, discusses the operational challenges involved.

The company said laboratories are dealing with greater complexity, rising testing demand and shortages of specialists. In that setting, informatics can help consolidate and present data consistently, while AI may support test utilization and reduce redundant work or workflow bottlenecks.

Data Quality Remains Central

QuidelOrtho also stressed that AI depends on underlying data being standardized, reliable and traceable. The episode presents AI as a support for clinical professionals rather than a replacement for their judgment; laboratory experts remain responsible for interpreting results and making final decisions.

The company highlighted transfusion medicine as one area where integrated information can be particularly useful because multiple data points influence clinical decisions. The podcast is an operational and technology update, not financial guidance.

Share Price Context

Lang & Schwarz quoted the shares at 12.31 euros on October 29, 2026, at 22:59:30 Berlin time. The snapshot showed a bid of 12.26 euros and an ask of 12.36 euros. No verified Xetra closing comparison is included here.

For investors, the update adds context to QuidelOrtho's efforts to position its diagnostics business around connected laboratory workflows. It does not by itself establish a change in revenue, earnings or customer adoption.